Yeqiang Liu

机构：Tongji University, Shanghai Skin Disease Hospital, Tongji Hospital · ORCID：0000-0003-3758-1390

发表论文 164 篇 · 总被引 2567 次 · h-index 28

代表论文

• Piezo1-Mediated Calcium Flux Transfers Mechanosignal to Yes-Associated Protein to Stimulate Matrix Production in Keloid (2025 · Journal of Investigative Dermatology · 被引 14)
• Ce6 derivative photodynamic therapy triggers PANoptosis and enhances antitumor immunity with LAG3 blockade in cutaneous squamous cell carcinoma (2025 · Cell Reports Medicine · 被引 11)
• Retrospective study on the correlation between CXCL13, immune infiltration, and tertiary lymphoid structures in cutaneous squamous cell carcinoma (2025 · PeerJ · 被引 6)
• CRKL silencing inhibits melanoma growth and enhances its chemotherapy sensitivity through the PI3K/AKT and NLRP3/GSDMD pathways (2025 · Biochemical Pharmacology · 被引 6)
• 123TiP: TROPION-Lung14: A phase III study of osimertinib ± datopotamab deruxtecan (Dato-DXd) as first-line (1L) treatment for patients with EGFR-mutated locally advanced or metastatic (LA/M) non-small cell lung cancer (NSCLC) (2025 · Journal of Thoracic Oncology · 被引 5)
• Diosmetin augments BRAF-targeted therapy via concurrent suppression of MAPK and STAT3 pathways in melanoma (2025 · European Journal of Pharmacology · 被引 4)